Obstructive Sleep Apnea: What It Does, Why It Matters, and How We Think About It

Physician Article Dr. Brian Harris
Obstructive Sleep Apnea: What It Does, Why It Matters, and How We Think About It
Why this matters

People often think sleep apnea is a noise problem. It is really a physiology problem. The noise is just the part the room can hear. Obstructive Sleep Apnea (OSA) happens when your airway repeatedly collapses during sleep, stressing your body and starving your brain of oxygen. It’s not just "loud snoring"—it’s a repeated breathing struggle that can lead to heart disease, stroke, and chronic exhaustion.

In plain language

Imagine trying to breathe through a straw that keeps getting pinched shut. That’s what happens in sleep apnea. When you fall asleep, your throat muscles relax. For some people, they relax so much that the airway narrows or closes completely.

Your brain has to "wake up" slightly to kickstart your breathing again, usually with a gasp or a snort. You might not remember these mini-awakenings, but they happen dozens (or hundreds) of times a night. This leaves you feeling like you barely slept, even if you were in bed for 8 hours. Common signs include loud snoring, waking up with a dry mouth or headache, and feeling "brain fog" all day.

Clinical deep dive

Obstructive Sleep Apnea (OSA) is characterized by repetitive episodes of partial (hypopnea) or complete (apnea) upper airway obstruction during sleep. These events lead to intermittent hypoxemia, hypercapnia, and large intrathoracic pressure swings.

Pathophysiology

  • Airway Collapsibility: The "Pcrit" (critical closing pressure) is reached when the negative pressure of inspiration exceeds the dilating force of the upper airway muscles.
  • Sympathetic Activation: Each respiratory event is typically terminated by a micro-arousal, triggering a surge in catecholamines. This leads to acute spikes in blood pressure and heart rate.
  • Long-term Sequelae: Chronic intermittent hypoxia and sympathetic over-activity contribute to endothelial dysfunction, systemic inflammation, and increased risk for hypertension, atrial fibrillation, and insulin resistance.

    • Clinical Evaluation and Phenotyping

    Diagnosis is based on the Apnea-Hypopnea Index (AHI)—the average number of events per hour.
  • AHI 5-15: Mild
  • AHI 15-30: Moderate
  • AHI >30: Severe
Treatment logic has shifted toward "Phenotyping," where we consider not just the anatomy, but also the "Arousal Threshold," "Loop Gain" (respiratory control stability), and "Muscle Responsiveness." This helps explain why some thin patients have severe OSA while some obese patients have only mild snoring.